Profound Medical Corp. (NASDAQ: PROF) reported Q2 EPS of $0.52, $0.79 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $2.22 million versus the consensus estimate of $4.03 million.

For earnings history and earnings-related data on Profound Medical Corp. (PROF) click here.